Brands, Medical Use, Clinical Data
- Antihypertensive Agents
- Central Alpha-Agonists
Brands / Synonyms
Adesipress; Catapres; Catapres-TTS; Catapresan; Catapressan; Catarpres; Catarpresan; Chlornidinum; Clonidin; Clonidine HCl; Clonidinhydrochlorid; Clonidinum [Inn-Latin]; Clonistada; Clorpres; Dixarit; Duraclon; Duraclont; Ipotensium; Isoglaucon; ST 155BS; Tenso-Timelets
For the treatment of hypertension and maybe used in prophylaxis of migraine or recurrent vascular headache; Menopausal flushing
Clonidine is an antihypertensive agent and an epidural agent for refractory cancer pain. Similar to guanabenz in mechanism of action, clonidine is used in the treatment of hypertension, opiate and nicotine withdrawal, vascular headaches, diabetic diarrhea, glaucoma, ulcerative colitis, Gilles de la Tourette's syndrome, menopause symptoms, severe pain in cancer patients refractory to opiate agonists, and neuropathic pain and in the diagnosis of pheochromocytoma.
Mechanism of Action
Clonidine acts as an agonist at presynaptic alpha(2)-receptors in the nucleus tractus solitarius of the medulla oblongata. Stimulation of these receptors results in the supression of efferent sympathetic pathways and the subsequent decrease in blood pressure and vascular tone in the heart, kidneys, and peripheral vasculature. Clonidine is also a partial agonist at presynaptic alpha(2)-adrenergic receptors of peripheral nerves in vascular smooth muscle.
Well absorbed following oral administration. Bioavailability following chronic administration is approximately 65%.
Oral LD50 is 150 mg/kg in rat and 30 mg/kg in dog. Symptoms of overdose include constriction of pupils of the eye, drowsiness, high blood pressure followed by a drop in pressure, irritability, low body temperature, slowed breathing, slowed heartbeat, slowed reflexes, and weakness.
Biotrnasformation / Drug Metabolism
Hepatic. Metabolized through minor pathways. The major metabolite, p-hydroxyclonidine, is present in concentrations less than 10% of those of unchanged clonidine in urine.
Clonidine HCl is contraindicated in patients with a history of sensitization or allergic reactions to clonidine.
Epidural administration is contraindicated in the presence of an injection site infection, in patients on
anticoagulant therapy, and in those with a bleeding diathesis. Administration of epidural clonidine HCl above the C4
dermatome is contraindicated since there are no adequate data to support such use
If a patient receiving clonidine hydrochloride is also taking tricyclic antidepressants, the effect of clonidine
may be reduced, thus necessitating an increase in dosage. Clonidine hydrochloride may enhance the CNS-depressive
effects of alcohol, barbiturates or other sedatives. Amitriptyline in combination with clonidine enhances the
manifestation of corneal lesions in rats
Clonidine may potentiate the CNS-depressive effect of alcohol, barbiturates or other sedating drugs. Narcotic
analgesics may potentiate the hypotensive effects of clonidine. Tricyclic antidepressants may antagonize the
hypotensive effects of clonidine. The effects of tricyclic antidepressants on clonidine's analgesic actions are not
Beta blockers may exacerbate the hypertensive response seen with clonidine withdrawl. Also, due to the potential
for additive effects such as bradycardia and AV block, caution is warranted in patients receiving clonidine with
agents known to affect sinus node function or AV nodal conduction (e.g., digitalis, calcium channel blockers,
There is one reported case of a patient with acute delirium associated with the simultaneous use of fluphenazine
and oral clonidine. Symptoms resolved when clonidine was withdrawn and recurred when the patient was rechallenged
Epidural clonidine may prolong the duration of pharmacologic effects of epidural local anesthetics, including both
sensory and motor blockade.